In four DCIS, SFRP2 expression was slightly reduced (mean IRS = 6.5; range 4–8; SD ± 1.9; median IRS = 7; Figure 5D, E) with one sample showing strong reduction (25%, IRS = 4). The gene discussed is IARS1; the disease is ductal breast carcinoma in situ.